Target Medicals is a pharmaceutical company specializing in the discovery and development of therapeutics targeting Cytochromes P450 (CYPs). CYPs are a superfamily of proteins found in all kingdoms of life and play a crucial role in various biochemical pathways. Target Medicals leverages their scientific expertise to perform rational drug discovery, aiming for target selectivity, efficacy, and safety profile.

At Target Medicals, crystallography is a vital aspect of their research. This multidisciplinary science enables them to optimize compounds effectively. By utilizing protein crystallization, they gain valuable insights into the structure of their target proteins, facilitating the development of innovative drug candidates.

The company's dedication to scientific excellence and cutting-edge research has contributed to its reputation in the industry, and they continue to forge partnerships and collaborations to further enhance their capabilities. For more information about Target Medicals' projects, partnership opportunities, and news updates, please visit their website